Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",48290,289,0.99 [0.86-1.13],0.8645866551445315
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",50025,382,0.99 [0.88-1.12],0.8889981109935646
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",49497,2686,1.06 [1.01-1.11],0.0118015079535564
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Candidiasis,50062,830,1.07 [0.99-1.16],0.0937929089980704
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,48538,6825,1.04 [1.01-1.07],0.0048034430117646
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),48743,6260,1.03 [1.00-1.06],0.0575014318140923
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,49577,2382,1.05 [1.00-1.09],0.0623550232375007
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,49887,169,0.88 [0.73-1.06],0.1687972389268446
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,46045,1887,1.04 [0.98-1.09],0.1963966119088757
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,44512,2155,1.04 [0.99-1.09],0.1224340345140048
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,44238,496,1.07 [0.96-1.18],0.2127487557196309
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,35195,3875,1.03 [1.00-1.07],0.0830111465338857
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,43953,759,1.09 [1.01-1.19],0.0303895693044375
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,49990,2795,1.03 [0.98-1.07],0.2198474453252461
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Mycoses,50209,977,1.07 [0.99-1.15],0.081868733397059
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,48616,1805,1.06 [1.01-1.12],0.0277134645250326
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,50081,2080,1.02 [0.97-1.07],0.4347836177017041
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,47578,383,0.99 [0.88-1.11],0.8426414649863703
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,50308,99,1.13 [0.90-1.41],0.2996342588759829
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other septicaemia,49823,1822,1.02 [0.97-1.08],0.3804163857472283
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,49864,146,1.15 [0.96-1.38],0.1385642848342347
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other viral diseases,50151,304,1.14 [1.00-1.29],0.0476068299952113
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",50115,268,1.13 [0.99-1.29],0.0782418344192697
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,47629,818,1.13 [1.04-1.22],0.0022337731480154
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,47344,533,1.01 [0.91-1.11],0.8614847475806219
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,47405,210,1.02 [0.88-1.20],0.763179232821307
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,50264,100,0.92 [0.73-1.16],0.4784990701833659
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,50181,292,0.96 [0.84-1.10],0.5214881381836178
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral warts,49987,98,0.98 [0.77-1.23],0.8466708386937927
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],50010,121,0.91 [0.73-1.12],0.3770916933095111
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm,49733,574,0.96 [0.87-1.05],0.3738076201539362
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,50134,114,1.08 [0.88-1.33],0.4624256984552604
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,50100,122,1.11 [0.91-1.36],0.2942280509843382
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23124,127,0.86 [0.69-1.06],0.1587828103972305
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",49658,2802,1.01 [0.97-1.06],0.554852273666059
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm of meninges,50281,111,1.25 [1.02-1.54],0.0325713437581987
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,50182,126,1.02 [0.83-1.25],0.8748430084345368
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,50258,202,1.02 [0.87-1.20],0.7866761162496994
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm of ovary,27056,171,1.00 [0.84-1.19],0.9942564895217684
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Ascending colon,50261,698,1.00 [0.91-1.09],0.9465735945657724
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Caecum,50263,587,0.98 [0.89-1.08],0.7066930434698195
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",50093,139,0.89 [0.73-1.08],0.2419488112779414
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Descending colon,50258,421,1.00 [0.89-1.11],0.938368321250425
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Rectum,50183,682,0.98 [0.90-1.07],0.6584425187062635
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,50083,1197,1.00 [0.94-1.07],0.991381154854536
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Transverse colon,50245,837,1.02 [0.95-1.11],0.5634759668207432
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Carcinoma in situ of breast,22008,134,0.72 [0.58-0.89],0.0020125615747984
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22099,164,0.94 [0.78-1.12],0.4756223670170719
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",40089,100,0.82 [0.64-1.05],0.1093164004191709
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",40123,134,0.95 [0.78-1.16],0.6078644867496635
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",50211,230,0.99 [0.85-1.15],0.8985957970610028
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Haemangioma, any site",50212,226,1.00 [0.86-1.16],0.9753019818564892
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Leiomyoma of uterus,26159,574,0.97 [0.88-1.06],0.4682338718612304
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Lung cancer and mesothelioma,34911,647,1.08 [0.99-1.17],0.0880172859105391
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Lymphoid leukaemia,40089,100,0.90 [0.71-1.14],0.3975480105639475
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",40357,368,1.05 [0.93-1.18],0.4155841653792446
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",40382,393,0.97 [0.87-1.10],0.6653928351052982
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22228,185,0.94 [0.79-1.12],0.4935346874666533
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",40144,155,1.04 [0.87-1.25],0.6559982190883655
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",40195,206,1.06 [0.91-1.24],0.4524137539226932
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",40177,188,0.98 [0.82-1.16],0.7815349247799489
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22182,139,1.02 [0.84-1.23],0.8566411220529153
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",40169,180,1.02 [0.86-1.21],0.8413716134526307
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19303,1357,0.97 [0.91-1.04],0.3972084633770812
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",40207,218,0.98 [0.84-1.15],0.8206573062726137
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",40131,142,1.18 [0.98-1.42],0.0757333940209265
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,40196,207,1.05 [0.89-1.23],0.5692225481230351
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Melanocytic naevi,49928,393,0.96 [0.85-1.08],0.4652654730397925
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Melanocytic naevi of trunk,50232,169,1.00 [0.83-1.19],0.9584328599616324
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Melanoma in situ,40055,159,1.09 [0.91-1.31],0.3280047707990795
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",40165,176,0.90 [0.75-1.08],0.2544806805047471
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",40301,312,1.00 [0.88-1.14],0.9942526841676184
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",40432,443,1.04 [0.94-1.15],0.4796357411943561
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",40180,191,1.13 [0.96-1.33],0.130189855406566
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Other benign neoplasms of skin,49951,293,0.95 [0.83-1.09],0.4563882307713894
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",42080,2091,0.97 [0.93-1.02],0.3095276627090093
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",42193,2204,0.98 [0.94-1.03],0.4889656548644295
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,49747,661,0.96 [0.88-1.05],0.4201765489415605
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,46623,218,0.97 [0.83-1.14],0.7308247027551799
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,49221,135,1.16 [0.96-1.40],0.1301092291342731
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,48763,5639,1.03 [1.00-1.06],0.0728420736547418
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,47437,96,1.03 [0.82-1.30],0.7833475046293493
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,49492,100,1.07 [0.85-1.34],0.5846421511061809
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,49357,2952,1.04 [1.00-1.08],0.0645292874087224
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,49356,2951,1.04 [1.00-1.08],0.0708665499828472
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,46573,168,0.95 [0.79-1.13],0.5383598286647826
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,49670,2329,1.09 [1.04-1.14],0.0005688330033562
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,49616,224,0.91 [0.77-1.06],0.2152615207271781
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,49209,123,1.05 [0.85-1.28],0.6695970874815137
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,49202,116,1.07 [0.87-1.32],0.5357653298069655
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,49933,541,0.81 [0.73-0.90],6.642753734428179e-05
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,50102,107,1.05 [0.85-1.31],0.6311768156759254
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",49838,446,0.71 [0.63-0.79],6.916273589288233e-09
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,47546,205,1.02 [0.87-1.19],0.8332499416118748
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,38900,616,0.99 [0.90-1.08],0.7861167278620911
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,46907,225,1.07 [0.92-1.25],0.3658377297289497
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,46926,244,1.13 [0.98-1.30],0.0982799691908303
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,38392,108,1.18 [0.96-1.46],0.1150496308987384
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,46722,133,0.94 [0.77-1.14],0.517251550715846
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,45623,463,1.00 [0.90-1.11],0.968770100426678
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",49375,1115,1.00 [0.93-1.07],0.9935787991074628
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,48783,523,0.96 [0.86-1.06],0.3906431055906814
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,48514,254,1.19 [1.04-1.37],0.0122895095984717
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,49617,3028,1.06 [1.02-1.10],0.005255512367616
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,43804,2934,1.07 [1.03-1.12],0.0015972917471776
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",38415,131,0.88 [0.71-1.08],0.2263417395720708
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",46377,155,0.99 [0.83-1.20],0.9464986608947294
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,38831,547,1.12 [1.02-1.23],0.0213926991212154
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,38401,117,1.30 [1.07-1.59],0.0089296361980903
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,45181,6897,1.07 [1.04-1.10],6.919522010222555e-07
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,38658,374,1.04 [0.92-1.17],0.5488708366926127
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,39366,1082,1.09 [1.02-1.17],0.0095331310597938
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,50146,628,1.06 [0.97-1.16],0.1987021444819411
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,49779,261,1.00 [0.87-1.15],0.9893279428599888
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,38534,250,1.06 [0.92-1.23],0.3953170214195797
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",38401,117,1.02 [0.82-1.26],0.8643866946319504
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,49251,3029,1.02 [0.98-1.06],0.3737101955035483
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,38789,505,1.07 [0.97-1.18],0.1924830335014601
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,38863,579,0.99 [0.90-1.09],0.8681741889458738
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",39520,1236,1.11 [1.04-1.18],0.001523423007097
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,38518,234,0.94 [0.81-1.10],0.4279776296045976
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,49763,245,0.99 [0.85-1.14],0.8415386512602113
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,39468,1184,1.06 [0.99-1.13],0.0898727398418769
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,39229,945,1.05 [0.98-1.13],0.1868025112940868
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,45298,138,1.11 [0.92-1.34],0.2825073021481105
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,47998,9714,1.06 [1.04-1.09],2.901863177012888e-07
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,46319,97,0.98 [0.78-1.24],0.8588534721404331
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,46332,110,0.99 [0.80-1.23],0.9394134367534488
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,49944,3789,0.96 [0.93-1.00],0.0412120912848311
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",49945,3783,0.96 [0.93-1.00],0.0455472671019614
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,46324,102,1.15 [0.93-1.44],0.1992182792447937
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,49639,2348,1.05 [1.00-1.10],0.0611142592990779
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",41378,3094,1.03 [0.99-1.08],0.1121241276186521
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,50282,442,1.01 [0.91-1.13],0.8329589212232188
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,48422,162,1.08 [0.90-1.29],0.4035122286004071
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,47491,200,1.00 [0.85-1.18],0.9879082756761982
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,47566,275,1.20 [1.05-1.37],0.0059471109655853
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",38611,327,1.24 [1.10-1.40],0.0004024859366811
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,45793,298,0.98 [0.85-1.12],0.7250269563818256
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,4103,164,0.98 [0.82-1.18],0.8509128512486115
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,4377,493,0.98 [0.88-1.09],0.7099309135179359
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,45615,120,1.01 [0.83-1.24],0.9003234122859445
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,4047,111,0.86 [0.69-1.09],0.2143836889203917
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,49060,3565,1.06 [1.02-1.10],0.0026204150719522
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,48956,696,0.91 [0.83-1.00],0.0462688156696608
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,45871,711,1.04 [0.96-1.13],0.3635170842417662
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,39787,1503,1.06 [1.00-1.13],0.0397462650896706
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",50084,478,0.92 [0.82-1.02],0.1098385486230469
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),48130,321,0.90 [0.79-1.03],0.1197850760387836
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Angina pectoris,45927,2326,1.02 [0.97-1.07],0.3981147767568976
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Aortic aneurysm,48279,470,0.92 [0.82-1.02],0.1186513971068118
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,47925,116,1.20 [0.98-1.47],0.0753368885788889
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",48199,390,1.08 [0.97-1.21],0.1730611340505202
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,31198,3703,0.97 [0.94-1.01],0.196964807057265
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,AV-block,42394,833,0.99 [0.91-1.07],0.7979804533533005
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",50193,826,0.91 [0.84-0.99],0.0256091646161956
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Cardiac arrest,27874,379,1.13 [1.01-1.27],0.0332138953939655
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Cardiomyopathy,41892,331,0.95 [0.83-1.08],0.3984979297795463
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",41748,187,0.99 [0.83-1.17],0.8737942087841657
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,50305,100,1.23 [0.99-1.53],0.0640326824445621
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Conduction disorders,43594,2033,0.98 [0.94-1.04],0.5617916398215062
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,47630,4062,1.06 [1.02-1.10],0.0023403735668478
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,43878,14700,1.04 [1.02-1.06],0.0002754099061901
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,DVT of lower extremities,47615,517,0.95 [0.86-1.05],0.3079708001895075
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Endocarditis,41704,143,1.09 [0.90-1.32],0.3606935457409556
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Heart failure, strict",49905,2138,1.02 [0.97-1.07],0.4631662560721421
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypertension,45663,12639,1.04 [1.02-1.06],5.152601350489082e-05
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Hypertension, essential",45697,12673,1.04 [1.02-1.06],5.896063811135848e-05
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Hypertension, portal",49977,145,0.82 [0.67-1.00],0.0478167160396477
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",33365,341,1.03 [0.91-1.17],0.5908786570173069
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,33291,267,1.08 [0.94-1.25],0.2614083613465043
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypotension,50022,2296,1.04 [0.99-1.09],0.0854573860827815
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,48511,213,1.00 [0.85-1.17],0.9950111654320584
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",47954,4353,1.06 [1.02-1.10],0.0009505871028085
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",49573,1085,1.08 [1.01-1.16],0.0275296258936636
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Left bundle-branch block,42262,701,1.03 [0.94-1.12],0.5342321550039622
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,49375,1637,1.04 [0.99-1.10],0.1412892079294726
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",44986,1385,1.07 [1.00-1.13],0.0346285478305998
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",50128,297,1.15 [1.02-1.31],0.0274111356847362
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",50251,609,0.98 [0.89-1.08],0.6761948071727923
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Oesophageal varices,47200,102,0.80 [0.63-1.02],0.0756541928226423
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other aneurysm,47959,150,0.89 [0.73-1.08],0.2317783875650946
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other arrhythmias,42385,824,1.04 [0.96-1.12],0.3893042419157309
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,48006,197,1.18 [1.01-1.38],0.0332614700663619
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,48267,458,0.95 [0.86-1.06],0.3855275255320968
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,41910,349,0.96 [0.85-1.08],0.4921783513959417
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other disorders of veins,47290,192,0.94 [0.80-1.11],0.472279974523121
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,47190,92,1.10 [0.87-1.38],0.4371931832144793
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,47508,122,0.94 [0.76-1.17],0.5900901646618724
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,47360,262,0.99 [0.86-1.14],0.8808553916212519
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,43570,2009,0.96 [0.91-1.01],0.1303279057667315
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,47832,106,0.84 [0.67-1.06],0.1485152335724057
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,48860,1051,1.04 [0.97-1.11],0.2920033940473303
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,49108,673,1.03 [0.94-1.12],0.5388588281736608
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",48577,1191,1.01 [0.95-1.08],0.6980130623167196
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,28155,660,0.95 [0.87-1.04],0.2777578894075661
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Peripheral artery disease,48533,782,1.02 [0.94-1.10],0.6711218530790748
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),47772,674,0.98 [0.90-1.07],0.6461261454934708
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Pulmonary embolism,49358,923,0.97 [0.90-1.05],0.423093968861128
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,50170,1281,0.98 [0.92-1.05],0.6100396323106078
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Right bundle-branch block,42239,678,0.96 [0.88-1.05],0.3763235275866555
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Secondary right heart disease,49099,664,1.03 [0.94-1.12],0.5355146430392695
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,47765,379,1.03 [0.92-1.16],0.6249981577941421
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",49550,1252,1.07 [1.00-1.14],0.0396362641340079
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",49509,1326,1.06 [0.99-1.13],0.0716632688519063
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,48459,116,0.96 [0.77-1.18],0.6776806975852181
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,47965,157,0.81 [0.67-0.98],0.0322247391025804
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Transient ischemic attack,48948,460,1.05 [0.95-1.17],0.3400909827932213
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,48240,502,1.02 [0.92-1.13],0.7132934201369422
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Varicose veins,47923,825,0.99 [0.91-1.07],0.7285485640766125
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,47838,170,0.91 [0.76-1.09],0.3194729283464599
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Venous thromboembolism,49860,1458,0.97 [0.91-1.03],0.2540654659710702
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",50071,697,1.05 [0.97-1.14],0.2507955578074127
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",43994,2774,1.06 [1.02-1.11],0.0053787646873322
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Any mental disorder,49031,7811,1.04 [1.01-1.07],0.0020339573150723
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",49979,823,1.03 [0.96-1.12],0.4024059091357406
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",44304,3084,1.07 [1.02-1.11],0.0020080160185101
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",41398,178,1.12 [0.94-1.32],0.2030674351715108
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Smoking dependency,49269,2678,1.06 [1.02-1.11],0.0073146078699835
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",44402,3182,1.06 [1.02-1.10],0.0068029904499427
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Vascular dementia,49302,250,0.91 [0.78-1.05],0.1925286303184025
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Alzheimer disease,50307,647,0.98 [0.90-1.08],0.6856079365305174
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",33904,115,1.04 [0.84-1.28],0.7459610176286264
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Bell's palsy,46846,156,0.99 [0.82-1.19],0.914325079339922
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,47634,944,1.02 [0.94-1.09],0.6674219809854196
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Cerebral cysts,49521,451,1.00 [0.90-1.11],0.9958373669387184
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,50151,628,1.00 [0.91-1.09],0.98291195600548
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,49326,96,1.10 [0.88-1.39],0.4086963293882124
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,50276,119,1.05 [0.85-1.29],0.6747133634157789
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",49212,142,0.98 [0.80-1.19],0.8184548408120791
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Epilepsy,47263,555,1.01 [0.92-1.12],0.7889395014973453
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,49365,2657,1.03 [0.99-1.08],0.128401261929838
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,50223,1183,1.03 [0.96-1.10],0.4406127886520868
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Falls/tendency to fall,49148,5046,0.99 [0.96-1.03],0.7293425182527544
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Generalized epilepsy,49567,104,1.17 [0.95-1.45],0.142858774194702
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Hemiplegia,50012,489,1.04 [0.94-1.15],0.4659055323266735
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Hydrocephalus,49192,122,1.14 [0.93-1.39],0.1980232573250126
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,50270,129,1.13 [0.93-1.38],0.2121345785961947
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,46833,143,0.85 [0.70-1.04],0.1143676790250839
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,46842,152,1.03 [0.86-1.24],0.7454757251758779
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Memory loss,49020,214,0.92 [0.79-1.08],0.327286326439052
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Migraine,47407,699,1.04 [0.96-1.14],0.316609447208085
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",50168,629,1.05 [0.96-1.14],0.3309358813455112
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Motor neuron disease,34090,264,1.08 [0.94-1.25],0.2626789621706231
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,49985,202,1.07 [0.92-1.25],0.3941120211524218
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",48999,2309,1.02 [0.97-1.07],0.3943004548985972
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Neurological diseases,47424,7330,1.02 [1.00-1.05],0.1063571956424783
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,49626,396,1.06 [0.95-1.19],0.3122713079168547
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",47494,804,1.07 [0.99-1.16],0.0885087935806105
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",50159,572,1.05 [0.95-1.15],0.3342234778873619
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,40019,1266,1.05 [0.98-1.11],0.1741315235759648
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,49214,144,0.95 [0.78-1.15],0.5861951184569437
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other disorders of nervous system,49343,273,0.88 [0.76-1.01],0.0700957535446021
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,49363,323,1.05 [0.93-1.19],0.4328075684515814
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other facial nerve disorders,46873,183,0.98 [0.82-1.16],0.7971123962361447
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other headache syndromes,46816,108,1.18 [0.95-1.46],0.125708623828545
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other neurological diseases,50079,1009,1.01 [0.94-1.09],0.727603278740133
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other sleep disorders,47790,1082,1.02 [0.95-1.09],0.6277952416787764
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Parkinson's disease,50261,834,1.02 [0.94-1.10],0.69912905029963
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,49179,109,1.04 [0.84-1.30],0.6942980486986597
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Restless leg syndrome,50306,154,1.04 [0.86-1.25],0.6922200199567973
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Sleep apnoea,49831,931,1.02 [0.95-1.10],0.6185669361927694
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Small fibre neuropathy,49680,93,1.17 [0.93-1.47],0.1808346946282026
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,50282,316,1.07 [0.94-1.21],0.3274116653635424
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,46787,97,0.85 [0.67-1.08],0.1801497213682174
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,50307,654,0.98 [0.90-1.07],0.6768170269311156
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),49231,243,0.91 [0.78-1.06],0.2053553821655621
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,49195,194,1.08 [0.92-1.27],0.3318430670343327
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,49517,773,1.02 [0.93-1.10],0.7203405682714143
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,49965,457,0.96 [0.86-1.07],0.4517353938719627
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,48355,103,0.95 [0.75-1.20],0.6605036627263855
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,48366,114,1.29 [1.06-1.58],0.0113632407699884
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",50099,95,1.18 [0.94-1.47],0.16101731457183
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,49794,287,1.07 [0.94-1.22],0.3201446709851892
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",4058,119,0.88 [0.71-1.10],0.2642722692052595
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,4926,195,1.00 [0.85-1.18],0.9997875896981824
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,49180,179,1.09 [0.92-1.29],0.2997453134348192
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,49887,2026,1.03 [0.98-1.09],0.1883232794372351
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",49591,1339,1.02 [0.95-1.08],0.6350186653272993
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,48689,437,1.09 [0.97-1.21],0.1343618431625032
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",50142,1398,1.03 [0.97-1.10],0.3197605618531665
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,50287,132,1.15 [0.95-1.40],0.1567771437348201
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,49999,1255,1.03 [0.97-1.10],0.3326557203936104
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",50223,716,1.02 [0.94-1.11],0.6655774510053613
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,50126,348,1.08 [0.96-1.22],0.2124244673763684
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,48366,114,0.97 [0.78-1.20],0.7648956632627338
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,48380,128,1.02 [0.83-1.25],0.8682015166924504
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,48361,109,1.06 [0.85-1.32],0.6099801558504524
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,50129,1373,1.02 [0.96-1.08],0.597519339420085
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,49114,358,1.00 [0.89-1.13],0.9949614983380056
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,48838,94,0.96 [0.76-1.22],0.7463287157710787
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,49701,194,0.95 [0.80-1.12],0.5086719729002309
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,50041,534,1.04 [0.94-1.15],0.4491070262878744
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,49117,373,1.07 [0.95-1.20],0.2621842284885515
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,49993,215,1.05 [0.90-1.23],0.5239212142207497
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,49671,915,1.05 [0.98-1.14],0.1655641445535463
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,49276,275,1.04 [0.91-1.19],0.5769740929046776
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,47171,4199,1.04 [1.01-1.08],0.0200950500499554
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,49970,463,1.04 [0.94-1.16],0.4689782198471455
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,50267,297,1.08 [0.95-1.24],0.2220528798054111
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,49036,784,0.96 [0.89-1.05],0.3765698393961977
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,49632,125,0.84 [0.68-1.04],0.1084877968213471
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,50263,108,1.16 [0.94-1.44],0.1627953897985923
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,48415,163,0.89 [0.74-1.07],0.2149650491322245
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,48537,285,0.95 [0.82-1.09],0.4247070979081067
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,48093,232,1.16 [1.00-1.34],0.0497277951080577
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,48864,120,1.02 [0.83-1.26],0.8267302091610843
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",47980,119,0.86 [0.69-1.08],0.1916262511475477
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,48924,168,0.94 [0.78-1.12],0.4761129935824151
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",49135,379,0.97 [0.86-1.10],0.6679799335121397
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,48495,243,1.01 [0.87-1.17],0.9213865055790792
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,48075,214,1.19 [1.03-1.39],0.0216144265669498
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,48024,163,1.02 [0.85-1.22],0.8573288613440314
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,46489,3517,1.02 [0.98-1.06],0.320730788532247
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,48392,140,1.02 [0.84-1.24],0.8510745062281391
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,49803,802,1.08 [1.00-1.17],0.0616517230469492
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,49115,114,1.07 [0.87-1.33],0.5041070272159165
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),49332,331,1.11 [0.98-1.26],0.0925416053999149
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,49895,170,0.96 [0.80-1.14],0.6346925015224886
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,50216,234,0.96 [0.83-1.12],0.6259141573309663
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,50051,244,1.12 [0.97-1.29],0.118328038182963
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,49838,113,1.10 [0.89-1.36],0.3731906989127035
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,49842,117,0.98 [0.79-1.21],0.832873179512648
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,50108,1742,0.98 [0.93-1.04],0.5660705521818372
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,49615,1249,1.00 [0.94-1.07],0.953921415567018
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,48610,244,0.89 [0.77-1.04],0.1393449068889418
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,48534,168,1.07 [0.90-1.27],0.4597981836627252
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Acute pharyngitis,49832,143,0.83 [0.68-1.01],0.0609238282353864
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,50101,412,0.86 [0.77-0.97],0.0139342335193734
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,49813,124,0.84 [0.68-1.04],0.1119756224519137
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,All influenza,46386,229,0.96 [0.82-1.11],0.5658463505127747
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),46381,224,0.98 [0.84-1.14],0.8001402668195279
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Allergic asthma (mode),34489,225,1.06 [0.92-1.24],0.4152860948933816
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Allergic rhinitis,50051,540,1.03 [0.93-1.13],0.6207240640897531
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",37151,3409,1.05 [1.01-1.09],0.0168032163422509
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",37622,3358,1.05 [1.01-1.09],0.012349955476868
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),49524,267,1.06 [0.92-1.22],0.4040147949397608
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",46316,159,1.12 [0.94-1.33],0.2107659370473674
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Bronchiectasis,43654,691,1.08 [0.99-1.17],0.0844639882755256
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",43075,112,1.17 [0.96-1.44],0.126460359014706
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,48353,5390,1.05 [1.02-1.08],0.002551413841621
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",47628,137,0.96 [0.79-1.17],0.6827939088425523
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Chronic sinusitis,47790,299,1.18 [1.04-1.33],0.0125650958832012
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",49920,2313,1.05 [1.00-1.10],0.0551987205270745
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Deviated nasal septum,47703,212,1.05 [0.90-1.22],0.5542058545610442
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,46300,10224,1.04 [1.02-1.07],0.0001446403369901
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",48207,716,1.05 [0.96-1.14],0.3036457807022384
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Early onset COPD,48215,608,1.05 [0.96-1.15],0.2640944298092681
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Emphysema,43571,608,1.19 [1.09-1.29],7.889456962579728e-05
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,47805,550,1.07 [0.97-1.18],0.1635489140727486
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Influenza and pneumonia,49872,3715,1.05 [1.01-1.09],0.011520649390449
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Interstitial lung disease,47869,614,1.08 [0.99-1.18],0.0997743615068551
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Later onset COPD,48382,1705,1.05 [0.99-1.10],0.1076342033176553
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,50283,637,1.02 [0.94-1.12],0.5993981657389584
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Nasal polyp,47693,202,1.04 [0.89-1.22],0.6152005073545201
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,49820,1867,1.06 [1.00-1.11],0.0430594061076629
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other diseases of pleura,49848,3852,1.05 [1.01-1.09],0.0075284815500374
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,49115,1624,1.06 [1.00-1.12],0.0333486487694836
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other pleural conditions,46098,102,0.95 [0.75-1.19],0.6534932170405585
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,50136,768,1.07 [0.99-1.17],0.0838232454857467
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,50101,2520,1.07 [1.02-1.12],0.0028992441200669
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pleural effusion,47912,1916,1.04 [0.99-1.10],0.1031274118566283
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pleural plaque,46295,299,1.00 [0.87-1.14],0.9421648408264194
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",49387,3230,1.05 [1.01-1.10],0.0096804702587079
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,50159,513,1.01 [0.92-1.12],0.7846568382326106
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pneumothorax,46223,227,0.97 [0.83-1.13],0.6507628080548732
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pollen allergy,50261,462,1.06 [0.95-1.17],0.3047884871494249
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pulmonary oedema,49496,128,1.05 [0.86-1.28],0.6524267691559761
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Respiratory insufficiency,34371,107,1.20 [0.97-1.48],0.0919011720840587
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,49781,1828,1.05 [1.00-1.11],0.0601287292313755
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,48033,542,1.03 [0.93-1.14],0.5584974282198236
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Viral pneumonia,46635,478,1.02 [0.92-1.13],0.6972956618918282
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",49552,395,0.99 [0.89-1.12],0.927800095820695
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23203,216,1.01 [0.86-1.18],0.8854825079515816
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,35525,126,1.15 [0.94-1.40],0.1684186364509413
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute appendicitis,49995,286,1.00 [0.88-1.15],0.9592683108288048
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute gastritis,37874,180,1.06 [0.90-1.26],0.4693107846048322
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute pancreatitis,46727,346,1.08 [0.96-1.22],0.200499253332828
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute peritonitis,49395,181,1.05 [0.88-1.24],0.5949437664474535
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Alcoholic liver disease,48578,144,0.93 [0.76-1.12],0.4315015426997732
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Barrett oesophagus,38534,840,0.97 [0.90-1.05],0.5069977443474966
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",46577,196,0.95 [0.81-1.13],0.5786719289543882
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",49489,196,0.95 [0.80-1.12],0.5436799543801435
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Cholecystitis,46770,389,0.98 [0.87-1.10],0.745157246311754
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Cholelithiasis,48307,1926,1.04 [0.99-1.09],0.1479727745313745
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Chronic gastritis,38288,594,1.04 [0.95-1.15],0.355859767270497
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Chronic pancreatitis,46477,96,0.94 [0.75-1.20],0.6307287496030252
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",50028,196,0.83 [0.70-0.98],0.0297058248323469
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Coeliac disease,47191,240,1.08 [0.93-1.25],0.3058385600989917
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Collagenous colitis,47034,159,0.99 [0.83-1.19],0.9315666949673056
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,50008,362,1.01 [0.89-1.13],0.9253602082667186
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Constipation,49810,3260,0.99 [0.95-1.03],0.5831259769408572
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Crohn disease,47057,182,1.11 [0.94-1.31],0.2008852693292739
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",49618,132,1.01 [0.83-1.24],0.8991917868652161
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Crohn's disease NAS,47047,172,1.14 [0.97-1.35],0.1192739814730841
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Dental caries,48880,445,1.13 [1.02-1.25],0.0243591546760249
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,45179,4338,1.02 [0.99-1.06],0.2561275698658944
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of appendix,50066,357,1.02 [0.91-1.15],0.7045954505854712
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of liver,50071,1637,1.00 [0.94-1.06],0.9213156946491612
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",46080,8386,1.01 [0.98-1.04],0.4564049718854897
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",49498,1063,1.07 [1.00-1.15],0.0508752409137454
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of peritoneum,50136,922,1.05 [0.97-1.13],0.1978366486911996
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,48653,218,1.05 [0.90-1.23],0.5117910820587801
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of salivary glands,48368,130,1.06 [0.87-1.29],0.5583418554603865
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of the digestive system,49708,2757,1.01 [0.97-1.06],0.5864029637820467
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of tongue,48398,215,0.91 [0.78-1.07],0.2506759668383998
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",49088,2707,1.05 [1.00-1.09],0.0431034479559736
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,41534,6135,1.02 [0.99-1.05],0.3114808226460332
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Duodenal ulcer,38083,389,1.04 [0.93-1.17],0.4612840758477377
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",50144,312,1.02 [0.89-1.16],0.7925763739682871
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,50131,106,1.12 [0.90-1.39],0.312218852736797
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,48672,238,0.88 [0.75-1.02],0.0924415464163446
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,35686,287,1.02 [0.89-1.16],0.8222432220805485
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Functional dyspepsia,38764,1070,1.04 [0.97-1.11],0.2783969957561244
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastric ulcer,38393,699,1.04 [0.95-1.13],0.4290003024177466
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,42539,4845,1.02 [0.98-1.05],0.3214727809432237
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,38741,1047,1.03 [0.96-1.10],0.4464423318528576
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,38942,16119,1.01 [1.00-1.03],0.1255607631317611
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,GI-bleeding,49216,2265,1.00 [0.96-1.05],0.8954709704454581
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,48540,105,0.97 [0.77-1.21],0.7640708712319209
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,37301,2455,1.02 [0.97-1.06],0.5098065901367647
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",48555,121,0.91 [0.74-1.13],0.4108626325052515
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Hernia,47143,6302,1.01 [0.98-1.04],0.5444292204758427
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Impacted teeth,50144,98,1.22 [0.98-1.51],0.0813564888805451
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Impaction of intestines,35510,111,1.17 [0.94-1.44],0.1530861719557366
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Inguinal hernia,42585,1744,0.99 [0.94-1.05],0.6965020672847286
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",41041,200,1.00 [0.85-1.18],0.997920295832315
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,35588,189,1.01 [0.85-1.19],0.9494339890904416
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Intestinal malabsorption,47226,275,1.09 [0.96-1.25],0.1900136722550548
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,36471,1072,1.03 [0.96-1.11],0.3471413448347118
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,50249,720,1.08 [0.99-1.17],0.0732222004129602
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,48344,1469,1.03 [0.97-1.09],0.3135139970973241
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,48827,1952,1.03 [0.98-1.09],0.1931342582083967
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oesophageal obstruction,38058,364,1.04 [0.92-1.17],0.5492961943747765
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oesophagitis,38866,1172,1.01 [0.95-1.08],0.6987496014172758
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,50209,265,1.08 [0.94-1.23],0.3032745372094341
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,40973,132,1.16 [0.95-1.41],0.1361372994616607
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,38054,2655,1.04 [0.99-1.08],0.0990539920165663
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,46932,551,1.05 [0.96-1.16],0.3009454124476195
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,46685,304,1.06 [0.93-1.20],0.3975255904909848
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of intestine,38804,3405,1.00 [0.96-1.04],0.9201027496709387
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of intestines,46393,10994,1.00 [0.98-1.02],0.9340059498890012
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,48352,402,1.08 [0.97-1.21],0.1603019932579308
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of liver,49773,1339,1.00 [0.94-1.06],0.9727590302074924
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,38975,1281,1.00 [0.94-1.07],0.9886951419985583
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of pancreas,46672,291,0.97 [0.85-1.11],0.6519201829693774
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,50003,789,1.05 [0.97-1.14],0.2097308798062472
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,39540,1846,0.97 [0.92-1.03],0.3290446216070494
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,49244,2293,1.00 [0.96-1.05],0.8744350456477535
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,48786,351,1.11 [0.99-1.25],0.079364159616356
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,38747,3348,0.99 [0.95-1.03],0.5715504874456241
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),41619,3925,1.01 [0.97-1.05],0.652728659987027
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,48623,189,0.81 [0.68-0.97],0.0210588889467177
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,48592,1717,1.01 [0.96-1.07],0.6234889512334267
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",36065,666,1.02 [0.93-1.11],0.7247797575157146
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,50112,123,1.12 [0.92-1.37],0.2575057922484187
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,36353,954,1.00 [0.93-1.08],0.956139722688674
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",47238,287,1.10 [0.96-1.25],0.1652612977001874
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Recurring oral aphthae,50285,110,0.86 [0.69-1.08],0.2024548585217899
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,48443,223,1.04 [0.89-1.21],0.6265362061520219
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Toxic colitis,46983,108,0.84 [0.67-1.06],0.1341190231333343
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,38210,516,1.15 [1.04-1.27],0.0045899216094895
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ulcerative colitis,47182,307,1.18 [1.04-1.33],0.0111824842648198
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",47130,255,1.17 [1.02-1.34],0.0287007073471968
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Umbilical hernia,41367,526,0.94 [0.85-1.04],0.2118388329993349
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,35743,344,0.97 [0.86-1.10],0.6262472623344418
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ventral hernia,41340,499,1.02 [0.92-1.13],0.6561215297802309
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Volvulus,35558,159,0.90 [0.74-1.08],0.249678122038285
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,50148,576,0.94 [0.86-1.04],0.2397166371891307
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,49680,139,1.08 [0.90-1.31],0.4016169516708142
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,46310,311,1.03 [0.91-1.18],0.6101226210827142
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,49056,1349,1.03 [0.97-1.10],0.3143316477811914
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",48045,338,1.04 [0.92-1.18],0.509227671033827
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,46788,789,1.01 [0.93-1.10],0.8173434321001547
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,49707,538,1.09 [0.99-1.20],0.0748908368342834
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,50109,940,1.04 [0.96-1.12],0.3266000505727456
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,49263,94,1.03 [0.82-1.30],0.797846106925608
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,47263,6239,1.01 [0.98-1.04],0.3844847427341044
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,49419,870,1.00 [0.92-1.08],0.9284420616580727
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,49166,617,0.98 [0.89-1.08],0.6831258422430887
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,49538,1831,1.04 [0.98-1.09],0.1893214230202254
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",50276,105,0.94 [0.75-1.18],0.61219815067398
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,46112,113,0.92 [0.74-1.14],0.4407688377310816
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,48650,101,1.09 [0.87-1.36],0.4468955112104347
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,49688,519,1.08 [0.98-1.19],0.1233225244254503
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,46884,885,0.98 [0.91-1.06],0.6432946347439634
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,46122,123,0.92 [0.74-1.13],0.4270779739479711
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,50135,166,0.96 [0.80-1.15],0.6747546394747219
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,48078,371,1.15 [1.03-1.29],0.014903668554061
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,49916,375,0.94 [0.83-1.06],0.2846553327582384
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,49293,124,1.06 [0.87-1.30],0.560160316638971
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,46127,128,0.98 [0.80-1.21],0.8657165449869719
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,49175,3176,1.01 [0.97-1.05],0.7539944886062555
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",46955,956,1.00 [0.93-1.08],0.9876994440000108
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,46129,130,0.93 [0.75-1.14],0.4706682176377762
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,50136,595,0.98 [0.90-1.08],0.7525787178370179
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,49302,133,0.93 [0.76-1.14],0.4922873685388449
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,50029,488,0.99 [0.89-1.10],0.8489075321118691
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,50203,631,0.92 [0.84-1.01],0.0815369894148061
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,46244,245,1.07 [0.92-1.23],0.3729091335550897
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,46525,526,0.94 [0.85-1.04],0.2043777433734951
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,50182,610,0.92 [0.84-1.01],0.0885116364143609
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",46457,458,1.05 [0.94-1.16],0.3968611244511024
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,50244,275,1.01 [0.88-1.16],0.8959825710149338
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,43135,211,1.07 [0.91-1.25],0.4162696818340269
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,45799,10969,1.03 [1.00-1.05],0.0176382720832434
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,43044,8214,1.03 [1.00-1.05],0.0348202643686103
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,43068,144,0.95 [0.79-1.16],0.625948939044297
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,43613,297,1.08 [0.95-1.23],0.2544087552738866
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,43666,350,1.08 [0.95-1.21],0.2309366988434852
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,49818,180,1.02 [0.87-1.21],0.7782345941109879
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",43509,193,0.90 [0.76-1.06],0.213997323258589
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,37040,2210,1.05 [1.00-1.10],0.064253484902862
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",50041,367,1.05 [0.93-1.18],0.4555384796527364
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,44187,871,1.04 [0.96-1.12],0.3087099422001336
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,42532,14122,1.02 [1.00-1.04],0.0203745343889204
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,46446,225,0.90 [0.77-1.05],0.1879967949495514
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,43218,294,1.02 [0.89-1.17],0.7557801520976897
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,44033,1109,1.04 [0.97-1.11],0.2738106452228366
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,48502,5186,1.04 [1.00-1.07],0.0256704570226053
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,43455,531,0.99 [0.90-1.10],0.8778136377047687
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,43347,423,1.16 [1.04-1.29],0.0070253886016182
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,43185,261,1.09 [0.95-1.26],0.2090098641816944
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,49065,130,0.87 [0.71-1.07],0.1987796339008493
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,38108,3278,1.04 [1.00-1.08],0.0724145210789296
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,35998,1168,1.04 [0.98-1.12],0.2032572699807366
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",50163,1152,1.04 [0.98-1.12],0.2025658111933196
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,34973,143,1.14 [0.94-1.37],0.1731432251954322
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),35483,653,0.95 [0.87-1.04],0.2688510510659758
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,43517,593,1.00 [0.91-1.10],0.9321684578091496
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,36064,1234,1.04 [0.97-1.11],0.2470232784649364
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,43424,108,1.16 [0.93-1.43],0.1838871934063698
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,44547,1231,1.06 [1.00-1.13],0.0658214526668077
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,43913,597,1.08 [0.99-1.19],0.0974602574092258
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,35985,1155,1.03 [0.97-1.11],0.3371350760096062
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,43078,154,1.24 [1.05-1.48],0.0138777754530852
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",43046,122,1.11 [0.91-1.36],0.2939824191399408
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,46356,135,0.99 [0.82-1.21],0.9553267602566692
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,49547,3326,0.99 [0.95-1.03],0.5495300138055108
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,48403,2182,0.98 [0.94-1.03],0.5233481406014362
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",50025,878,1.12 [1.04-1.21],0.0023965367772818
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,39672,4842,1.04 [1.01-1.08],0.0099950616942874
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,34953,123,1.00 [0.81-1.23],0.9869446746059312
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,43106,182,1.11 [0.94-1.31],0.2213586269571495
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,34925,95,1.02 [0.80-1.29],0.8687248989562175
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),35077,247,1.00 [0.86-1.15],0.9629915923912508
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,46693,472,1.00 [0.90-1.11],0.9560009634503944
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,46962,741,1.01 [0.93-1.10],0.8356371921359597
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,50241,197,1.06 [0.90-1.25],0.4679181854796442
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",46831,3515,1.04 [1.00-1.08],0.0309072258689657
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,43116,192,1.01 [0.86-1.19],0.877972518309313
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),35100,270,0.91 [0.78-1.05],0.1755822624187527
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,44729,1413,1.03 [0.97-1.10],0.30748092525669
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,39007,4177,1.03 [0.99-1.06],0.1537140513613255
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,49111,176,0.88 [0.74-1.05],0.1635969379201377
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,50269,133,1.12 [0.92-1.36],0.2571348360480799
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,43083,159,1.06 [0.89-1.27],0.5044638216998594
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",45351,2427,1.07 [1.02-1.12],0.0036133744440472
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,43097,173,1.13 [0.96-1.34],0.1489045958864103
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,37981,3151,1.03 [0.99-1.08],0.0995926182566042
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,46440,219,1.03 [0.88-1.20],0.6882829781764943
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,43029,105,1.18 [0.95-1.47],0.1268990113834898
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,43620,304,0.99 [0.87-1.13],0.9059110493425376
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,44005,1081,1.02 [0.95-1.09],0.6512131005849546
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,49624,689,1.07 [0.98-1.17],0.1223584815745192
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,44434,1118,1.03 [0.96-1.10],0.4023456297746207
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,50049,854,1.12 [1.04-1.21],0.0026064179984479
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,50262,107,1.28 [1.04-1.58],0.0183853723993837
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,43295,371,0.97 [0.86-1.09],0.5749280618704262
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,39822,1463,1.07 [1.01-1.14],0.019823042442748
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,44061,1137,1.06 [0.99-1.13],0.1031618750525132
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],43373,449,1.01 [0.90-1.12],0.9277994785529636
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",34936,106,0.96 [0.76-1.20],0.6945893893272114
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,39657,4827,1.05 [1.02-1.08],0.0040679526958178
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,36101,1271,1.01 [0.95-1.08],0.7365323585731773
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,49391,456,1.05 [0.94-1.17],0.3957426784747123
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",50175,131,0.93 [0.76-1.14],0.4731938100934091
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",46099,99,0.92 [0.73-1.17],0.5167870579863384
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,34965,135,1.12 [0.92-1.35],0.266032104433155
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,43517,201,1.14 [0.97-1.33],0.1094560488386416
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,35719,889,1.12 [1.04-1.21],0.0020928223800712
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,43527,603,1.02 [0.93-1.12],0.6209253474768957
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,43808,492,1.14 [1.03-1.26],0.0103718496374207
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,43691,375,1.04 [0.93-1.17],0.4685449343304855
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,39371,117,1.23 [1.00-1.50],0.0445857530204975
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",50270,115,1.19 [0.97-1.45],0.1014141647895114
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,44075,1151,1.02 [0.96-1.10],0.4743164549279036
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],49113,178,1.08 [0.92-1.28],0.350343625030084
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,47940,5016,1.04 [1.00-1.07],0.0300165608660453
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",43182,258,0.98 [0.85-1.13],0.8085893461532315
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,44388,1072,1.07 [1.00-1.15],0.0596809052136859
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,47579,448,0.97 [0.87-1.08],0.5232699944538748
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,43715,399,1.05 [0.93-1.17],0.438065152196601
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,46353,3037,1.03 [0.99-1.07],0.1560820509962872
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,45314,1998,1.05 [1.00-1.10],0.0654750314145397
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],43028,104,1.11 [0.89-1.38],0.3576778882752671
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,49191,256,0.97 [0.84-1.12],0.6813219471106725
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,43242,318,1.06 [0.93-1.21],0.3583265680732669
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,43073,149,0.92 [0.76-1.12],0.4235347513782797
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),34944,114,1.03 [0.83-1.28],0.7764688965572966
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Acute renal failure,48268,3058,1.03 [0.99-1.07],0.1596302646160487
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20292,100,1.04 [0.83-1.30],0.745104334366016
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26439,112,0.98 [0.79-1.21],0.8262878073178659
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,49687,620,1.05 [0.96-1.15],0.2953059604905739
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,49228,161,0.86 [0.71-1.04],0.1111056469498868
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,48182,2972,0.98 [0.94-1.03],0.4552236791638163
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,49884,161,0.94 [0.78-1.13],0.5135834116250868
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,49825,587,1.07 [0.97-1.17],0.1651375635881579
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Cystitis,44319,459,1.04 [0.93-1.15],0.524853057701753
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Dialysis,45365,155,1.07 [0.89-1.29],0.4492576352761472
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,21916,3238,1.02 [0.98-1.06],0.3046733501959959
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Disorders of breast,26666,339,0.96 [0.85-1.09],0.5679303010254748
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Endometriosis,20368,176,0.96 [0.80-1.14],0.6192428658678653
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",20583,391,0.94 [0.84-1.06],0.3129670943694347
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21189,997,1.03 [0.95-1.10],0.4849563640018026
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,41979,10454,1.01 [0.99-1.03],0.3997727838657675
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,49890,167,1.03 [0.86-1.23],0.7443939862723963
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Hydrocele,18876,198,0.93 [0.78-1.10],0.3867636200232873
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,45187,564,1.01 [0.91-1.11],0.9164391032891256
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21216,2538,1.02 [0.98-1.07],0.3150150004741656
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,26597,393,0.99 [0.88-1.11],0.8977832011411249
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),18909,231,0.96 [0.82-1.12],0.5925548706586858
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Irregular menses,26670,126,0.87 [0.70-1.07],0.1774080644043763
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Menorrhagia,20493,301,1.01 [0.88-1.15],0.9023943828517208
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,44010,150,0.99 [0.82-1.20],0.941911695437704
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,22629,2437,1.00 [0.96-1.05],0.92140879991385
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,18788,110,0.95 [0.76-1.19],0.6639151833791566
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20332,140,1.08 [0.89-1.30],0.4299348055565799
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",50281,123,1.08 [0.88-1.33],0.453549666380606
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",50290,127,0.91 [0.74-1.11],0.3494275197564113
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,48274,4414,1.03 [0.99-1.06],0.1387115730314717
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,45248,1388,1.02 [0.96-1.09],0.464870181541416
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26444,117,0.96 [0.78-1.19],0.7196953289045704
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,50172,934,1.07 [1.00-1.16],0.060070023302358
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,18984,306,1.01 [0.88-1.15],0.8974915775894026
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,18957,279,0.97 [0.84-1.12],0.6745258580984944
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,18899,221,0.91 [0.77-1.07],0.2526205118881974
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,50229,137,0.99 [0.81-1.20],0.9079581860218522
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,47265,3405,1.03 [0.99-1.07],0.1155955513825075
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26402,198,1.02 [0.87-1.20],0.8174122389089069
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20346,154,1.08 [0.90-1.30],0.3834235206934254
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20557,365,0.98 [0.87-1.11],0.7899696574280411
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20300,108,0.97 [0.78-1.21],0.8087772746069428
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20398,206,1.06 [0.91-1.24],0.4476069486711026
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,45281,658,1.00 [0.92-1.10],0.9240590727268012
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,49549,311,1.05 [0.92-1.19],0.4919949155809999
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20501,309,1.00 [0.88-1.13],0.9596169072193352
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20297,105,0.95 [0.76-1.19],0.6727732246021608
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,20826,634,1.03 [0.94-1.13],0.4918191748490329
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,20351,159,1.10 [0.92-1.31],0.2848979950979404
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,20778,586,1.07 [0.98-1.18],0.1308002672049554
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,49820,97,1.02 [0.81-1.29],0.8457255353081116
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",18940,262,1.08 [0.94-1.25],0.2661871045906178
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,49813,5190,1.01 [0.98-1.04],0.523480547928298
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",44853,230,1.06 [0.91-1.23],0.4336107564421082
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,45465,255,0.84 [0.73-0.98],0.0284843570628317
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,49173,106,0.97 [0.78-1.21],0.7882303029506642
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Urethral stricture,44294,434,1.04 [0.93-1.16],0.5298427589705381
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Urolithiasis,49832,765,1.01 [0.93-1.10],0.8007029020807074
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20328,136,1.17 [0.97-1.41],0.1075688791515063
